Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart

Biomaterials

Volumn 35, Issue 25, 2014, Pages 6850-6858

  Roche, Ellen T ^a,b   Hastings, Conn L ^c,d   Lewin, Sarah A ^b   Shvartsman, Dmitry E ^a,b   Brudno, Yevgeny ^a,b   Vasilyev, Nikolay V ^e   O'Brien, Fergal J ^c,d   Walsh, Conor J ^a,b   Duffy, Garry P ^c,d   Mooney, David J ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Alginate; Cell viability; Collagen; Heart; Hydrogel

Indexed keywords

ALGINATE; BIOMATERIALS; COLLAGEN; CYTOLOGY; FLUORESCENCE; HEART; HYDROGELS; PHOSPHOLIPIDS; STEM CELLS;

CELL VIABILITY; DELIVERY TECHNIQUES; HUMAN MESENCHYMAL STEM CELLS (HMSCS); IMMUNOHISTOCHEMICAL ANALYSIS; INJECTABLE HYDROGELS; MYOCARDIAL INFARCTS; POST-IMPLANTATION; PROMISING THERAPY;

BIOLOGICAL MATERIALS;

ALGINIC ACID; BIOMATERIAL; CHITOSAN; COLLAGEN; GLYCEROL 2 PHOSPHATE; SODIUM CHLORIDE; BETA-GLYCEROPHOSPHORIC ACID; GLUCURONIC ACID; GLYCEROPHOSPHATE; HEXURONIC ACID; HYDROGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HEART INFARCTION; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; INTRACARDIAC PATCH; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; STEM CELL TRANSPLANTATION; ANIMAL; BLOOD; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FEMALE; IMMOBILIZED CELL; MESENCHYMAL STROMA CELL; MYOCARDIAL INFARCTION; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING;

RATTUS;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CELLS, CULTURED; CELLS, IMMOBILIZED; CHITOSAN; COLLAGEN; FEMALE; GLUCURONIC ACID; GLYCEROPHOSPHATES; HEXURONIC ACIDS; HUMANS; HYDROGELS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING;

EID: 84902077185     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.114     Document Type: Article

References (38)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127(1):e6-e245.
2. Wang H., Zhou J., Liu Z., Wang C. Injectable cardiac tissue engineering for the treatment of myocardial infarction. JCell Mol Med 2010, 14(5):1044-1055.
3. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.a., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25(9):1015-1024.
4. Ashraf M., Dimmeler S., Robey T.E., Saiget M.K., Reinecke H., Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. JMol Cell Cardiol 2008, 45(4):567-581.
5. Hou D., Youssef E.A.-S., Brinton T.J., Zhang P., Rogers P., Price E.T., et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005, 112(9 Suppl.):150-156.
6. Yu J., Du K.T., Fang Q., Gu Y., Mihardja S.S., Sievers R.E., et al. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 2010, 31(27):7012-7020.
7. Aicher A., Brenner W., Zuhayra M., Badorff C., Massoudi S., Assmus B., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003, 107(16):2134-2139.
8. Blocklet D., Toungouz M., Berkenboom G., Lambermont M., Unger P., Preumont N., et al. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells 2006, 24(2):333-336.
9. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111(17):2198-2202.
10. Cheng K., Li T.-S., Malliaras K., Davis D.R., Zhang Y., Marbán E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106(10):1570-1581.
11. Terrovitis J., Lautamäki R., Bonios M., Fox J., Engles J.M., Yu J., et al. Noninvasive quantification and optimization of acute cell retention by invivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. JAm Coll Cardiol 2009, 54(17):1619-1626.
12. Quevedo H.C., Hatzistergos K.E., Oskouei B.N., Feigenbaum G.S., Rodriguez J.E., Valdes D., et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U. S. A 2009, 106(33):14,022-14,027.
13. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. JMol Cell Cardiol 2001, 33(5):907-921.
14. Venugopal J.R., Prabhakaran M.P., Mukherjee S., Ravichandran R., Dan K., Ramakrishna S. Biomaterial strategies for alleviation of myocardial infarction. JR Soc Interface 2012, 9(66):1-19.
15. Hastings C.L., Kelly H.M., Murphy M.J., Barry F.P., O'Brien F.J., Duffy G.P. Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia. JControl Release 2012, 161(1):73-80.
16. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20(1):45-53.
17. Alsberg E., Anderson K.W., Albeiruti A., Rowley J.A., Mooney D.J. Engineering growing tissues. Proc Natl Acad Sci U. S. A 2002, 99(19):12,025-12,030.
18. Lee K.Y., Rowley J.A., Eiselt P., Moy E.M., Bouhadir K.H., Mooney D.J. Controlling mechanical and swelling properties of alginate hydrogels independently by cross-linker type and cross-linking density. Macromolecules 2000, 33(11):4291-4294.
19. Thornton A.J., Alsberg E., Albertelli M., Mooney D.J. Shape-defining scaffolds for minimally invasive tissue engineering. Transplantation 2004, 77(12):1798-1803.
20. O'Brien F.J., Harley B.A., Yannas I.V., Gibson L.J. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 2005, 26(4):433-441.
21. Mylotte L.A., Duffy A.M., Murphy M., O'Brien T., Samali A., Barry F., et al. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 2008, 26(5):1325-1336.
22. Sutton E.J., Boddington S.E., Nedopil A.J., Henning T.D., Demos S.G., Baehner R., et al. An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis. Opt Express 2009, 17(26):24403-24413.
23. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473(7347):326-335.
24. Li M., Mondrinos M.J., Gandhi M.R., Ko F.K., Weiss A.S., Lelkes P.I. Electrospun protein fibers as matrices for tissue engineering. Biomaterials 2005, 26(30):5999-6008.
25. Hamdi H., Furuta A., Bellamy V., Bel A., Puymirat E., Peyrard S., et al. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 2009, 87(4):1196-1203.
26. Smith R.R., Marbán E., Marbán L. Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel. Biomatter 2013, 3(1):e24490.
27. Qian L., Shim W., Gu Y., Shirhan M., Lim K.P., Tan L.P., et al. Hemodynamic contribution of stem cell scaffolding in acute injured myocardium. Tissue Eng Part A 2012, 18(15, 16):1652-1663.
28. Johnson T.D., Christman K.L. Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction. Expert Opin Drug Deliv 2013, 10(1):59-72.
29. Liu Z., Wang H., Wang Y., Lin Q., Yao A., Cao F., et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials 2012, 33(11):3093-3106.
30. Lu W.-N., Lü S.-H., Wang H.-B., Li D.-X., Duan C.-M., Liu Z.-Q., et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng Part A 2009, 15(6):1437-1447.
31. Templin C., Lüscher T.F., Landmesser U. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. Int J Dev Biol 2011, 55(4-5):407-417.
32. Singelyn J.M., Christman K.L. Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. JCardiovasc Transl Res 2010, 3(5):478-486.
33. Malliaras K., Marban E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull 2011, 98:161-185.
34. Korf-Klingebiel M., Kempf T., Sauer T., Brinkmann E., Fischer P., Meyer G.P., et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008, 29(23):2851-2858.
35. Gnecchi M., He H., Noiseux N., Liang O.D., Zhang L., Morello F., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006, 20(6):661-669.
36. Collins M.C., Moore J.L.J., Burrows B.J., Kypson A.P., Muller-Borer B.J. Early cell loss associated with mesenchymal stem cell cardiomyoplasty. Open Tissue Eng Regen Med J 2012, 5:17-24.
37. Thornton A.J., Alsberg E., Hill E.E., Mooney D.J. Shape retaining injectable hydrogels for minimally invasive bulking. JUrol 2004, 172(2):763-768.
38. Bencherif S.A., Sands R.W., Bhatta D., Arany P., Verbeke C.S., Edwards D.A., et al. Injectable preformed scaffolds with shape-memory properties. Proc Natl Acad Sci USA 2012, 109(48):19590-19595.